Department of Vascular Surgery, The First Affiliated Hospital of Gannan Medical University.
Department of Thyroid Surgery, The First Affiliated Hospital of Gannan Medical University.
Int Heart J. 2023;64(4):750-758. doi: 10.1536/ihj.22-669.
Endothelial-mesenchymal transition (EndMT) and endothelial cell apoptosis have been documented to have a role in atherosclerosis (AS) progression. To deepen knowledge in this aspect, our study investigated the effect of LIM homeobox 2 (LHX2) and adhesion-regulating molecule 1 (ADRM1) on EndMT and endothelial cell apoptosis in the oxidized low-density lipoprotein (ox-LDL) -stimulated AS cell model.Ox-LDL was utilized to treat human umbilical vein endothelial cells (HUVECs) for constructing an AS model in vitro, followed by measurement of LHX2 and ADRM1 expressions. Afterward, gain- and loss-of-function assays were performed in HUVECs, followed by detection of cell viability, invasion, migration, and apoptosis and the expression of inflammatory factors [tumor necrosis factor (TNF) -α, interleukin (IL) -1β, and IL-6], EndMT-related proteins [CD31, vascular epithelium (VE) -cadherin, vimentin, α-smooth muscle actin (SMA), Snai1, Snai2, and Twist1], and the apoptotic protein cleaved caspase-3. Interactions between LHX2 and ADRM1 were analyzed with dual-luciferase reporter gene and chromatin immunoprecipitation assays.High levels of LHX2 and ADRM1 were observed in ox-LDL-induced HUVECs. In ox-LDL-treated HUVECs, LHX2, or ADRM1 knockdown promoted CD31 and VE-cadherin levels, viability, invasion, and migration and reduced apoptosis and the expressions of TNF-α, IL-1β, IL-6, vimentin, α-SMA, Snai1, Snai2, Twist1, and cleaved caspase-3. Mechanistically, LHX2 bound to the ADRM1 promoter to promote ADRM1 transcription. Overexpression of ADRM1 annulled the aforementioned effects of LHX2 knockdown on ox-LDL-induced HUVECs.LHX2 facilitates the pathological progression of ox-LDL-stimulated AS cell models by increasing ADRM1 transcription.
内皮-间质转化(EndMT)和内皮细胞凋亡已被证明在动脉粥样硬化(AS)进展中起作用。为了更深入地了解这一方面,我们的研究调查了 LIM 同源盒 2(LHX2)和黏附调节分子 1(ADRM1)对氧化低密度脂蛋白(ox-LDL)刺激的 AS 细胞模型中 EndMT 和内皮细胞凋亡的影响。使用 ox-LDL 处理人脐静脉内皮细胞(HUVEC),在体外构建 AS 模型,然后测量 LHX2 和 ADRM1 的表达。随后,在 HUVEC 中进行增益和失能实验,检测细胞活力、侵袭、迁移和凋亡以及炎症因子[肿瘤坏死因子(TNF)-α、白细胞介素(IL)-1β和 IL-6]、EndMT 相关蛋白[CD31、血管上皮(VE)-钙黏蛋白、波形蛋白、α-平滑肌肌动蛋白(SMA)、Snai1、Snai2 和 Twist1]和凋亡蛋白 cleaved caspase-3 的表达。使用双荧光素酶报告基因和染色质免疫沉淀分析检测 LHX2 和 ADRM1 之间的相互作用。在 ox-LDL 诱导的 HUVEC 中观察到 LHX2 和 ADRM1 的高表达。在 ox-LDL 处理的 HUVEC 中,LHX2 或 ADRM1 敲低促进 CD31 和 VE-钙黏蛋白水平、活力、侵袭和迁移,并降低凋亡以及 TNF-α、IL-1β、IL-6、波形蛋白、α-SMA、Snai1、Snai2、Twist1 和 cleaved caspase-3 的表达。从机制上讲,LHX2 结合到 ADRM1 启动子上,促进 ADRM1 转录。ADRM1 的过表达消除了 LHX2 敲低对 ox-LDL 诱导的 HUVEC 中上述作用。LHX2 通过增加 ADRM1 转录促进 ox-LDL 刺激的 AS 细胞模型的病理进展。